SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-344384
Filing Date
2012-08-08
Accepted
2012-08-08 17:21:13
Documents
13
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d344727d10q.htm 10-Q 644712
2 EX-10.2 d344727dex102.htm EX-10.2 681656
3 EX-10.3 d344727dex103.htm EX-10.3 47009
4 EX-31.1 d344727dex311.htm EX-31.1 6868
5 EX-31.2 d344727dex312.htm EX-31.2 6810
6 EX-32.1 d344727dex321.htm EX-32.1 4185
7 EX-32.2 d344727dex322.htm EX-32.2 4187
  Complete submission text file 0001193125-12-344384.txt   7043618

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT lgnd-20120630.xml EX-101.INS 1041412
9 XBRL TAXONOMY EXTENSION SCHEMA lgnd-20120630.xsd EX-101.SCH 53326
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lgnd-20120630_cal.xml EX-101.CAL 72095
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lgnd-20120630_def.xml EX-101.DEF 151166
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE lgnd-20120630_lab.xml EX-101.LAB 452676
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lgnd-20120630_pre.xml EX-101.PRE 318328
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 121017729
SIC: 2834 Pharmaceutical Preparations